Target intelligence / Profile preview

Lysine acetyltransferase 8 (KAT8)

Target
KAT8
Molecular classification
Enzyme, Histone modification, Transcription factor
01

Overview

Lysine acetyltransferase 8 (KAT8), also known as MOF or MYST1, is a member of the MYST family of histone acetyltransferases (HATs) that plays a critical role in chromatin remodeling and transcriptional regulation. It primarily catalyzes the acetylation of histone H4 at lysine 16 (H4K16ac), a key epigenetic mark that prevents chromatin compaction and promotes gene transcription. Additionally, KAT8 acetylates non-histone proteins, including the tumor suppressor p53, STAT3, and mitochondrial proteins, thereby regulating cell cycle progression, DNA damage repair, apoptosis, and mitochondrial homeostasis. Dysregulation of KAT8 is strongly implicated in various cancers, such as non-small cell lung cancer (NSCLC) and acute myeloid leukemia (AML), as well as neurodegenerative disorders like Parkinson's disease and inflammatory conditions like asthma. Consequently, KAT8 has emerged as a promising therapeutic target, with several small-molecule inhibitors, such as MG149 and KAT8-IN-1, being developed as preclinical tools to suppress tumor growth and alleviate inflammatory responses.

Other names
MOFMYST1hMOFMales-absent on the first protein homologMYST histone acetyltransferase 1Protein acetyltransferase KAT8Protein propionyltransferase KAT8
02

Mechanism of action

Inhibition of lysine acetyltransferase activity, leading to decreased histone H4 lysine 16 acetylation (H4K16ac) and suppression of target gene transcription.

03

Biological functions

Cell cycleApoptosisCell proliferationCell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseOther
05

Safety considerations

Global developmental delayIntellectual disabilityImpaired DNA damage repairPotential systemic toxicity due to broad epigenetic roleOff-target effects on other acetyltransferases
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Histone H4 lysine 16 acetylation (H4K16ac)p53 lysine 120 acetylation (p53K120ac)STAT3 acetylation

Beyond the preview

Go deeper on Lysine acetyltransferase 8 (KAT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine acetyltransferase 8 (KAT8).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call